(273 days)
No
The summary describes dental implants and their surface treatments, with no mention of AI or ML technology.
Yes
The device is intended to be surgically placed to provide support for prosthetic devices to restore chewing function, which addresses a medical condition or function.
No
The device is an implant system designed to provide support for prosthetic devices (artificial teeth) and restore chewing function. It is a treatment device, not a diagnostic one, as it does not gather or analyze data to identify a medical condition.
No
The device description clearly details physical implants made of titanium, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is "intended to be surgically placed in the bone of the upper or lower jaw to provide support for prosthetic devices such as artificial teeth, to restore chewing function." This describes a surgical implant for structural support, not a device used to examine specimens derived from the human body to provide information for diagnosis, monitoring, or treatment.
- Device Description: The description details the physical characteristics of dental implants (diameters, lengths, materials, surface treatments). This aligns with a surgical implant, not an IVD.
- Lack of IVD Characteristics: There is no mention of the device being used with biological samples (blood, urine, tissue, etc.), performing tests or assays, or providing diagnostic information.
Therefore, the Neodent Implant System, as described, is a surgical implant and not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Neodent Implant System is intended to be surgically placed in the bone of the upper or lower jaw to provide support for prosthetic devices such as artificial teeth, to restore chewing function. It may be used with single-stage or two-stage procedures, for single or multiple unit restorations, and may be loaded immediately when good primary stability is achieved and with appropriate occlusal loading. Multiple tooth applications may be rigidly splinted.
Product codes (comma separated list FDA assigned to the subject device)
DZE
Device Description
The subject Titamax Ti EX Acqua implants are provided in the same design variants as the predicate Titamax Ti EX implants. The only difference is the application of the Acqua hydrophilic surface treatment in place of the NeoPoros surface finish. The Titamax Ti EX Acqua are provided in two endosseous diameters (3.75 and 4.0 mm), one platform diameter (4.1 mm), and five lengths (9, 11, 13, 15, and 17 mm).
The subject Ti Drive Acqua implants have the same tapered, single thread design variants as the predicate CM Drive implants and the same external hex abutment interface and internal geometry as the predicate HE series implants. They also have the Acqua hydrophilic surface treatment in place of the NeoPoros surface finish. The Ti Drive Acqua implants are provided in three endosseous diameters (3.5, 4.3, and 5.0 mm), three platform diameters (3.3, 4.3, and 5.0 mm), and five lengths (8, 10, 11.5, 13, and 16 mm).
The subject Titamax CM EX Acqua implants are provided in the same design variants as the predicate Titamax CM EX implants. The only difference is the application of the Acqua hydrophilic surface treatment in place of the NeoPoros surface finish. The Titamax CM EX Acqua implants are provided in three endosseous diameters (3.5, 3.75, and 4.0 mm), three platform diameters (3.5, 3.75, and 4.0 mm), and five lengths (9, 11, 13, 15, 17 and 19 mm).
The subject CM Drive Acqua implants are provided in the same design variants as the predicate Titamax CM EX implants. The only difference is the application of the Acqua hydrophilic surface treatment in place of the NeoPoros surface finish. The CM Drive Acqua implants are provided in three endosseous diameters (3.5, 4.3, and 5.0 mm), three platform diameters (3.3, 4.3, and 5.0 mm), and five lengths (8, 10, 11.5, 13, and 16 mm).
The subject Titamax Smart EX Acqua implants are provided in the same design variants as the predicate. The only difference is the application of the Acqua hydrophilic surface treatment in place of the NeoPoros surface finish. The Titamax Smart EX Acqua implants are provided in two endosseous diameters (3.75 and 4.0 mm), one platform diameter (4.1 mm), and five lengths (9, 11, 13, 15, and 17 mm).
The subject device Drive Smart Acqua implants are provided in the same design variants as the predicate Drive Smart implants. The only difference is the application of the Acqua hydrophilic surface treatment in place of the NeoPoros surface finish. The Drive Smart Acqua implants are provided in three endosseous diameters (3.5, 4.3, and 5.0 mm), three platform diameters (3.3, 4.3, and 5.0 mm), and five lengths (8, 10, 11.5, 13, and 16 mm).
The Acqua surface finish is a traditional grit blast and acid etch surface that is further processed in a manner that renders it hydrophilic.
The subject implant devices are made of Grade 4 Materials: commercially pure titanium conforming to ASTM F67, Standard Specification for Unalloyed Titanium for Surgical Implant Applications (UNS R50250, UNS R50400, UNS R50550, UNS R50700), with a surface that is grit blasted, acid etched and subjected to a process that renders them hydrophilic. The subject Smart mount devices are made of titanium alloy conforming to ASTM F136 Standard for Titanium-6Aluminum-Specification 4Vanadium ELI (Extra Low Interstitial) Allov for Surgical Implant Applications (UNS R56401).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
bone of the upper or lower jaw
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical data submitted, referenced, or relied upon to demonstrate substantial equivalence include engineering analysis and dimensional analysis. Bench testing and animal testing were submitted to characterize the Acqua surface. The data included in this submission demonstrate substantial equivalence to the referenced predicate devices. Clinical data were not submitted in this premarket notification.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K101207 JJGC Indústria e Comércio de Materiais Dentários SA, Neodent Implant System, K101945 JJGC Indústria e Comércio de Materiais Dentários SA, Neodent Implant System, K123022 JJGC Indústria e Comércio de Materiais Dentários SA, Neodent Implant System, K133510
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.3640 Endosseous dental implant.
(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol representing the human form, depicted as three stylized profiles facing to the right. The profiles are connected and flow together, creating a sense of unity and collaboration.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
August 22, 2014
Neodent USA Incorporated Christopher Klaczyk Director of Regulatory Affairs 60 Minutemen Road Andover, MA 01810
Re: K133592
Trade/Device Name: Neodent Implant System Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: II Product Code: DZE Dated: July 24, 2014 Received: July 25, 2014
Dear Mr. Klaczyk:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Page 2 - Mr. Klaczyk
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Mary S. Runner -S
Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
4. Indications For Use
510(k) Number (if known):
Device Name: Neodent Implant System
Indications for Use:
The Neodent Implant System is intended to be surgically placed in the bone of the upper or lower jaw to provide support for prosthetic devices such as artificial teeth, to restore chewing function. It may be used with single-stage or two-stage procedures, for single or multiple unit restorations, and may be loaded immediately when good primary stability is achieved and with appropriate occlusal loading. Multiple tooth applications may be rigidly splinted.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
3
5. 510(k) Summary
| Manufacturer: | JJGC Indústria e Comércio de Materiais Dentários SA
Av. Juscelino Kubitschek de Oliveira, 3291 - CIC
Curitiba, Paraná, 81270-200, Brazil
Telephone: +55 41 2169 1003
Fax: +55 41 2169 1043
Establishment Registration No. 3008261720 |
|------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Official Contact: | Jafte Carneiro Fagundes da Silva
Chief Compliance, Legal and Regulatory Officer – CCLRO |
| Sponsor: | Christopher Klaczyk
Neodent USA, Inc.
60 Minuteman Road
Andover, MA 01810
Telephone +1 (978) 747-2572
Fax +1 (978) 747-0023
Email regulatory@neodentusa.com
Establishment Registration No. Pending |
| Date Prepared: | November 21, 2013 |
| Product Code(s): | DZE (21 CFR 872.3640) |
| Device Class: | II (21 CFR 872.3640) |
| Classification Panel: Dental Devices | |
| Classification Name: Endosseous dental implant | |
| | Proprietary Name: Neodent Implant System |
| | Predicate Device(s): Neodent Implant System is substantially equivalent in
indications and design principles to the following legally
marketed predicate devices:
JJGC Indústria e Comércio de Materiais Dentários SA,
Neodent Implant System, K101207 JJGC Indústria e Comércio de Materiais Dentários SA,
Neodent Implant System, K101945 JJGC Indústria e Comércio de Materiais Dentários SA,
Neodent Implant System, K123022 JJGC Indústria e Comércio de Materiais Dentários SA,
Neodent Implant System, K133510 |
- " Institut Straumann AG, SLActive Implants, K033984
4
- Device Description: The subject Titamax Ti EX Acqua implants are provided in the same design variants as the predicate Titamax Ti EX implants. The only difference is the application of the Acqua hydrophilic surface treatment in place of the NeoPoros surface finish. The Titamax Ti EX Acqua are provided in two endosseous diameters (3.75 and 4.0 mm), one platform diameter (4.1 mm), and five lengths (9, 11, 13, 15, and 17 mm).
The subject Ti Drive Acqua implants have the same tapered, single thread design variants as the predicate CM Drive implants and the same external hex abutment interface and internal geometry as the predicate HE series implants. They also have the Acqua hydrophilic surface treatment in place of the NeoPoros surface finish. The Ti Drive Acqua implants are provided in three endosseous diameters (3.5, 4.3, and 5.0 mm), three platform diameters (3.3, 4.3, and 5.0 mm), and five lengths (8, 10, 11.5, 13, and 16 mm).
The subject Titamax CM EX Acqua implants are provided in the same design variants as the predicate Titamax CM EX implants. The only difference is the application of the Acqua hydrophilic surface treatment in place of the NeoPoros surface finish. The Titamax CM EX Acqua implants are provided in three endosseous diameters (3.5, 3.75, and 4.0 mm), three platform diameters (3.5, 3.75, and 4.0 mm), and five lengths (9, 11, 13, 15, 17 and 19 mm).
The subject CM Drive Acqua implants are provided in the same design variants as the predicate Titamax CM EX implants. The only difference is the application of the Acqua hydrophilic surface treatment in place of the NeoPoros surface finish. The CM Drive Acqua implants are provided in three endosseous diameters (3.5, 4.3, and 5.0 mm), three platform diameters (3.3, 4.3, and 5.0 mm), and five lengths (8, 10, 11.5, 13, and 16 mm).
The subject Titamax Smart EX Acqua implants are provided in the same design variants as the predicate. The only difference is the application of the Acqua hydrophilic surface treatment in place of the NeoPoros surface finish. The Titamax Smart EX Acqua implants are provided in two endosseous diameters (3.75 and 4.0 mm), one platform
5
diameter (4.1 mm), and five lengths (9, 11, 13, 15, and 17 mm).
The subject device Drive Smart Acqua implants are provided in the same design variants as the predicate Drive Smart implants. The only difference is the application of the Acqua hydrophilic surface treatment in place of the NeoPoros surface finish. The Drive Smart Acqua implants are provided in three endosseous diameters (3.5, 4.3, and 5.0 mm), three platform diameters (3.3, 4.3, and 5.0 mm), and five lengths (8, 10, 11.5, 13, and 16 mm).
The Acqua surface finish is a traditional grit blast and acid etch surface that is further processed in a manner that renders it hydrophilic.
Intended Use: The Neodent Implant System is intended to be surgically placed in the bone of the upper or lower jaw to provide support for prosthetic devices such as artificial teeth, to restore chewing function. It may be used with single-stage or two-stage procedures, for single or multiple unit restorations, and may be loaded immediately when good primary stability is achieved and with appropriate occlusal loading. Multiple tooth applications may be rigidly splinted.
- The subject implant devices are made of Grade 4 Materials: commercially pure titanium conforming to ASTM F67, Standard Specification for Unalloyed Titanium for Surgical Implant Applications (UNS R50250, UNS R50400, UNS R50550, UNS R50700), with a surface that is grit blasted, acid etched and subjected to a process that renders them hydrophilic. The subject Smart mount devices are made of titanium alloy conforming to ASTM F136 Standard for Titanium-6Aluminum-Specification 4Vanadium ELI (Extra Low Interstitial) Allov for Surgical Implant Applications (UNS R56401).
- Performance Data: Non-clinical data submitted, referenced, or relied upon to demonstrate substantial equivalence include engineering analysis and dimensional analysis. Bench testing and animal testing were submitted to characterize the Acqua surface. The data included in this submission demonstrate substantial equivalence to the referenced predicate devices.
6
Clinical data were not submitted in this premarket notification.
- Conclusions: The implants of the subject Neodent Implant System have a similar design and dimensions, use similar materials and have a similar surface topology as those cleared under K101207, K101945, K123022 and K133510. The Acqua hydrophilic surface treatment is similar to the SLActive surface cleared in K033984.
Based upon our assessment of the performance data, the subject device is safe and effective for its intended use and performs as well as the referenced predicate device(s).